SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1

Abstract

In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different regulatory authority for manufacturing of product. Here SUPAC guidelines for USFDA are elaborated for production in this review article.

Authors and Affiliations

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B.

Keywords

Related Articles

Regulatory overview of biosimilars in Europe

A biosimilar is a biological medicine similar, but not identical, to an already registered reference bio therapeutic product in terms of quality, safety, and efficacy. These drugs are also called as biosimilar products„,...

HARMONIZATION & ADVANCEMENT IN PHARMACEUTICAL INDUSTRY

The urgent requirement to rationalize and harmonize regulation was impelled by instance of rising cost of Health care, Research and Development and need to meet the public requirement to approach for the safe and efficac...

OVERVIEW OF DRUG REGULATORY AFFAIRS AND REGULATORY PROFESSION

Pharmaceutical drug regulatory affairs govern registration parameters of pharmaceutical products. It has a broad spectrum covering all aspects of documentation and marketing in legalized form. The pharmaceutical industry...

MEDICAL DEVICES AND THEIR APPROVAL PROCEDURE IN INDIA

Therapeutic treatment based on medical devices is providing technologically advanced solutions for the management of several diseases. Thereby continues to grow in market at tremendous rate. However, these treatments als...

LYOPHILIZATION - PROCESS AND OPTIMIZATION FOR PHARMACEUTICALS

In this 21st century, Lyophilization emerges to be a novel trend for the drying of pharmaceuticals and biological that are thermolabile or are unstable in aqueous form but stable for longer periods in their dried form. T...

Download PDF file
  • EP ID EP326650
  • DOI 10.22270/ijdra.v5i1.192
  • Views 144
  • Downloads 0

How To Cite

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B. (2017). SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE. International Journal of Drug Regulatory Affairs, 5(1), 13-19. https://europub.co.uk/articles/-A-326650